Combination of epitope specific immunotherapy and anti-inflammatory therapy supresses arthritis through CD4+CD25+ regulatory T cells producing IL-10 and expressing FOXP3, as well as IL-10 producing CD4+CD25- T-cells.

S.T.A. Roord; T. Le; E. Huijssoon; E. Koffeman; G. Puga-Yung; W. Kuis; A.B.J. Prakken; S. Albani

Combination of epitope specific immunotherapy and anti-inflammatory therapy supresses arthritis through CD4+CD25+ regulatory T cells producing IL-10 and expressing FOXP3, as well as IL-10 producing CD4+CD25- T-cells.

Translated title of the contribution: Combination of epitope specific immunotherapy and anti-inflammatory therapy supresses arthritis through CD4+CD25+ regulatory T cells producing IL-10 and expressing FOXP3, as well as IL-10 producing CD4+CD25- T-cells.

S.T.A. Roord
, T. Le
, E. Huijssoon
, E. Koffeman
, G. Puga-Yung
, W. Kuis
, A.B.J. Prakken
, S. Albani

Cluster B

Research output: Contribution to journal › Meeting Abstract › Other research output

Translated title of the contribution	Combination of epitope specific immunotherapy and anti-inflammatory therapy supresses arthritis through CD4+CD25+ regulatory T cells producing IL-10 and expressing FOXP3, as well as IL-10 producing CD4+CD25- T-cells.
Original language	Undefined/Unknown
Journal	Clinical and Experimental Rheumatology
Volume	22
Issue number	4
Publication status	Published - 2004

Cite this

Roord, S. T. A., Le, T., Huijssoon, E., Koffeman, E., Puga-Yung, G., Kuis, W., Prakken, A. B. J., & Albani, S. (2004). Combination of epitope specific immunotherapy and anti-inflammatory therapy supresses arthritis through CD4+CD25+ regulatory T cells producing IL-10 and expressing FOXP3, as well as IL-10 producing CD4+CD25- T-cells. Clinical and Experimental Rheumatology, 22(4).

@article{f16991a7750a4f71a84f4c5cdad4edfc,

title = "Combination of epitope specific immunotherapy and anti-inflammatory therapy supresses arthritis through CD4+CD25+ regulatory T cells producing IL-10 and expressing FOXP3, as well as IL-10 producing CD4+CD25- T-cells.",

author = "S.T.A. Roord and T. Le and E. Huijssoon and E. Koffeman and G. Puga-Yung and W. Kuis and A.B.J. Prakken and S. Albani",

year = "2004",

language = "Undefined/Unknown",

volume = "22",

journal = "Clinical and Experimental Rheumatology",

issn = "0392-856X",

publisher = "Clinical and Experimental Rheumatology S.A.S.",

number = "4",

}

Roord, STA, Le, T, Huijssoon, E, Koffeman, E, Puga-Yung, G, Kuis, W, Prakken, ABJ & Albani, S 2004, 'Combination of epitope specific immunotherapy and anti-inflammatory therapy supresses arthritis through CD4+CD25+ regulatory T cells producing IL-10 and expressing FOXP3, as well as IL-10 producing CD4+CD25- T-cells.', Clinical and Experimental Rheumatology, vol. 22, no. 4.

Combination of epitope specific immunotherapy and anti-inflammatory therapy supresses arthritis through CD4+CD25+ regulatory T cells producing IL-10 and expressing FOXP3, as well as IL-10 producing CD4+CD25- T-cells. / Roord, S.T.A.; Le, T.; Huijssoon, E. et al.
In: Clinical and Experimental Rheumatology, Vol. 22, No. 4, 2004.

Research output: Contribution to journal › Meeting Abstract › Other research output

TY - JOUR

T1 - Combination of epitope specific immunotherapy and anti-inflammatory therapy supresses arthritis through CD4+CD25+ regulatory T cells producing IL-10 and expressing FOXP3, as well as IL-10 producing CD4+CD25- T-cells.

AU - Roord, S.T.A.

AU - Le, T.

AU - Huijssoon, E.

AU - Koffeman, E.

AU - Puga-Yung, G.

AU - Kuis, W.

AU - Prakken, A.B.J.

AU - Albani, S.

PY - 2004

Y1 - 2004

M3 - Meeting Abstract

SN - 0392-856X

VL - 22

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

IS - 4

ER -